ZEB2 and cancer: Furthermore, CM-PM increased the expression of the mesenchymal markers Slug, Zeb1, and Zeb2 and reduced the expression of the epithelial marker E-cadherin in cancer cells at both the transcriptional and translational levels (Fig. 5c, e).